[1] |
RAMOS-CASALS M, BRITO-ZERON P, LOPEZ-GUILLERMO A, et al.Adult haemophagocytic syndrome[J].Lancet, 2014, 383(9927):1503. doi: 10.1016/S0140-6736(13)61048-X |
[2] |
KUMAKURA S, MURAKAWA Y.Clinical characteristics and treatment outcomes of autoimmune-associated hemophagocytic syndrome in adults[J].Arthritis Rheumatol, 2014, 66(8):2297. doi: 10.1002/art.v66.8 |
[3] |
GUPTA S, WEITZMAN S.Primary and secondary hemophagocytic lymphohistiocytosis:clinical features, pathogenesis and therapy[J].Expert Rev Clin Immunol, 2010, 6(1):137. doi: 10.1586/eci.09.58 |
[4] |
TZANNOU I, BALTA AM, BAKIRI M.Hemophagocytic syndrome associated with hematologic malignancies[J].Hospital Chronicles, 2011, 6(3):110. |
[5] |
CHANDRAKASAN S, FILIPOVICH AH.Hemophagocytic lymphohistiocytosis:advances in pathophysiology, diagnosis, and treatment[J].J Pediatr, 2013, 163(5):1253. doi: 10.1016/j.jpeds.2013.06.053 |
[6] |
BAE CB, JUNG JY, KIM HA, et al.Reactive hemophagocytic syndrome in adult-onset Still disease:clinical features, predictive factors, and prognosis in 21 patients[J].Medicine(Baltimore), 2015, 94(4):e451. |
[7] |
赵东宝.挑战成人巨噬细胞活化综合征[J].中华风湿病学杂志, 2012, 16(7):433. doi: 10.3760/cma.j.issn.1007-7480.2012.07.001 |
[8] |
JIA J, SONG Y, LIN N, et al.Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndrome[J].Ann hematol, 2016, 95(12):2023. doi: 10.1007/s00277-016-2805-9 |
[9] |
RAVELLI A, MINOIA F, DAV S, et al.2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis:a European league against rheumatism/American college of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative[J].Arthritis Rheumatol, 2016, 68(3):566. doi: 10.1002/art.39332 |
[10] |
SCHULERT GS, GROM AA.Pathogenesis of macrophage activation syndrome and potential for cytokine-directed therapies[J].Annu Rev Med, 2015, 66:145. doi: 10.1146/annurev-med-061813-012806 |
[11] |
GROM AA, HORNE A, DE BENEDETTI F.Macrophage activation syndrome in the era of biologic therapy[J].Nat Rev Rheumatol, 2016, 12(5):259. |
[12] |
MARIA ATJ, QUELLEC AL, JORGENSEN C, et al.Adult onset Still's disease (AOSD) in the era of biologic therapies:dichotomous view for cytokine and clinical expressions[J].Autoimmunity Reviews, 2014, 13(11):1149. doi: 10.1016/j.autrev.2014.08.032 |
[13] |
EMILE JF, ABLA O, FRAITAG S, et al.Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages[J].Blood, 2016, 127(22):2672. doi: 10.1182/blood-2016-01-690636 |
[14] |
WEAVER LK, BEHRENS EM.Hyperinflammation, rather than hemophagocytosis, is the common link between macrophage activation syndrome and hemophagocytic lymphohistiocytosis[J].Curr Opin Rheumatol, 2014, 26(5):562. doi: 10.1097/BOR.0000000000000093 |